Issued Patents All Time
Showing 26–50 of 125 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10849870 | Pharmaceutical compositions comprising DGLA and use of same | John Climax, David Coughlan, James Dunne | 2020-12-01 |
| 10842768 | Compositions and methods for lowering triglycerides | Ian Osterloh, Pierre Wicker, Rene Braeckman, Paresh Soni | 2020-11-24 |
| 10842766 | Stable pharmaceutical composition and methods of using same | Ian Osterloh, Pierre Wicker, Rene Braeckman, Paresh Soni | 2020-11-24 |
| 10792267 | Methods of treating mixed dyslipidemia | Ian Osterloh, Pierre Wicker, Rene Braeckman, Paresh Soni | 2020-10-06 |
| 10722485 | Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy | Ian Osterloh, Pierre Wicker, Rene Braeckman, Paresh Soni | 2020-07-28 |
| 10675263 | Methods of reducing apolipoprotein C-III | Ian Osterloh, Pierre Wicker, Rene Braeckman, Paresh Soni, Joseph S. Zakrzewski | 2020-06-09 |
| 10632094 | Methods of treating hypertriglyceridemia | Ian Osterloh, Pierre Wicker, Rene Braeckman, Paresh Soni | 2020-04-28 |
| 10624870 | Methods of treating mixed dyslipidemia | Ian Osterloh, Pierre Wicker, Rene Braeckman, Paresh Soni | 2020-04-21 |
| 10610508 | Methods of reducing apolipoprotein C-III | Ian Osterloh, Pierre Wicker, Rene Braeckman, Paresh Soni, Joseph S. Zakrzewski | 2020-04-07 |
| 10570083 | Compositions comprising oxo-derivatives of fatty acids and methods of making and using same | John Climax, David Coughlan | 2020-02-25 |
| 10561631 | Methods of reducing RLP-C | Ian Osterloh, Pierre Wicker, Rene Braeckman, Paresh Soni | 2020-02-18 |
| 10544088 | Pharmaceutically acceptable salts of fatty acids | David Coughlan, Bill Downes | 2020-01-28 |
| 10537544 | Methods of treating hypertriglyceridemia | Ian Osterloh, Pierre Wicker, Rene Braeckman, Paresh Soni | 2020-01-21 |
| 10537543 | Pharmaceutical compositions comprising DGLA and use of same | John Climax, David Coughlan, James Dunne | 2020-01-21 |
| 10449172 | Stable pharmaceutical composition and methods of using same | Ian Osterloh, Pierre Wicker, Rene Braeckman, Paresh Soni | 2019-10-22 |
| 10314803 | Pharmaceutical composition comprising eicosapentaenoic acid and nicotinic acid and methods of using same | — | 2019-06-11 |
| 10292959 | Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy | Ian Osterloh, Pierre Wicker, Rene Braeckman, Paresh Soni | 2019-05-21 |
| 10265287 | Methods of reducing triglycerides and LDL-C | Ian Osterloh, Pierre Wicker, Rene Braeckman, Paresh Soni | 2019-04-23 |
| 10265290 | Methods of reducing apolipoprotein C-III | Ian Osterloh, Pierre Wicker, Rene Braeckman, Paresh Soni, Joseph S. Zakrzewski | 2019-04-23 |
| 10220013 | Methods of treating mixed dyslipidemia | Ian Osterloh, Pierre Wicker, Rene Braeckman, Paresh Soni | 2019-03-05 |
| 10166209 | Methods of reducing apolipoprotein C-III | Ian Osterloh, Pierre Wicker, Rene Braeckman, Paresh Soni, Joseph S. Zakrzewski | 2019-01-01 |
| 10105333 | Pharmaceutical compositions comprising DGLA and use of same | John Climax, David Coughlan, James Dunne | 2018-10-23 |
| 10047033 | Compositions comprising oxo-derivatives of fatty acids and methods of making and using same | John Climax, David Coughlan | 2018-08-14 |
| 10017453 | Pharmaceutically acceptable salts of fatty acids | David Coughlan, Bill Downes | 2018-07-10 |
| 10010517 | Stable pharmaceutical composition and methods of using same | Ian Osterloh, Pierre Wicker, Rene Braeckman, Paresh Soni | 2018-07-03 |